Y Intercept Hong Kong Ltd Sells 6,387 Shares of Danaher Co. (NYSE:DHR)

Y Intercept Hong Kong Ltd lessened its holdings in shares of Danaher Co. (NYSE:DHR) by 35.8% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 11,463 shares of the conglomerate’s stock after selling 6,387 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Danaher were worth $2,631,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. AMF Tjanstepension AB bought a new position in shares of Danaher in the third quarter worth about $5,923,000. Howard Capital Management Group LLC increased its holdings in shares of Danaher by 4.1% in the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock valued at $342,000 after purchasing an additional 48 shares in the last quarter. Allworth Financial LP raised its position in Danaher by 6.1% in the 3rd quarter. Allworth Financial LP now owns 5,337 shares of the conglomerate’s stock worth $1,484,000 after purchasing an additional 307 shares during the last quarter. Arkadios Wealth Advisors lifted its holdings in Danaher by 1.8% during the 3rd quarter. Arkadios Wealth Advisors now owns 3,572 shares of the conglomerate’s stock worth $993,000 after buying an additional 64 shares in the last quarter. Finally, First Financial Bankshares Inc boosted its position in Danaher by 0.5% in the 3rd quarter. First Financial Bankshares Inc now owns 42,759 shares of the conglomerate’s stock valued at $11,888,000 after buying an additional 226 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Danaher Trading Up 0.5 %

NYSE DHR opened at $211.23 on Tuesday. Danaher Co. has a one year low of $196.80 and a one year high of $281.70. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The firm has a market cap of $150.97 billion, a P/E ratio of 40.01, a P/E/G ratio of 2.66 and a beta of 0.83. The stock’s 50-day moving average is $226.25 and its 200-day moving average is $246.44.

Danaher (NYSE:DHR) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the company posted $2.09 EPS. Sell-side analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.32 dividend. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.61%. Danaher’s payout ratio is currently 24.24%.

Analysts Set New Price Targets

A number of research firms have recently weighed in on DHR. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a research report on Friday, December 13th. The Goldman Sachs Group set a $250.00 price objective on Danaher in a report on Wednesday, January 15th. Wolfe Research raised shares of Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a research note on Thursday, October 31st. Robert W. Baird dropped their price target on shares of Danaher from $277.00 to $268.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Finally, StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, December 14th. Seven investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $278.00.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 11.10% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.